196 related articles for article (PubMed ID: 33502714)
1. Rare cause of xanthinuria: a pediatric case of molybdenum cofactor deficiency B.
Lee EJ; Dandamudi R; Granadillo JL; Grange DK; Kakajiwala A
CEN Case Rep; 2021 Aug; 10(3):378-382. PubMed ID: 33502714
[TBL] [Abstract][Full Text] [Related]
2. [Molybdenum cofactor deficiency type B manifested as Leigh-like syndrome: a case report and literature review].
Tian XJ; Li X; Fang F; Liu ZM; Wu WJ; Liu K; Sun SZ
Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):119-124. PubMed ID: 33548958
[No Abstract] [Full Text] [Related]
3. Molybdenum cofactor deficiency mimics cerebral palsy: differentiating factors for diagnosis.
Kikuchi K; Hamano S; Mochizuki H; Ichida K; Ida H
Pediatr Neurol; 2012 Aug; 47(2):147-9. PubMed ID: 22759696
[TBL] [Abstract][Full Text] [Related]
4. [Xanthine oxidase deficiency (hereditary xanthinuria), molybdenum cofactor deficiency].
Sumi S; Wada Y
Nihon Rinsho; 1996 Dec; 54(12):3333-6. PubMed ID: 8976115
[TBL] [Abstract][Full Text] [Related]
5. [Hereditary xanthinuria and molybdenum cofactor deficiency].
Ichida K
Nihon Rinsho; 2003 Jan; 61 Suppl 1():377-82. PubMed ID: 12629751
[No Abstract] [Full Text] [Related]
6. Late-Onset Molybdenum Cofactor Deficiency Type A: A Treatable Cause of Developmental Delay.
Lund AM; Berland S; Tangeraas T; Christensen M; Confer N; Squires L; Brannsether B
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38808412
[TBL] [Abstract][Full Text] [Related]
7. Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients.
Zaki MS; Selim L; El-Bassyouni HT; Issa MY; Mahmoud I; Ismail S; Girgis M; Sadek AA; Gleeson JG; Abdel Hamid MS
Eur J Paediatr Neurol; 2016 Sep; 20(5):714-22. PubMed ID: 27289259
[TBL] [Abstract][Full Text] [Related]
8. Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II.
Ichida K; Matsumura T; Sakuma R; Hosoya T; Nishino T
Biochem Biophys Res Commun; 2001 Apr; 282(5):1194-200. PubMed ID: 11302742
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II).
Stiburkova B; Pavelcova K; Petru L; Krijt J
Toxicol Appl Pharmacol; 2018 Aug; 353():102-108. PubMed ID: 29935280
[TBL] [Abstract][Full Text] [Related]
10. Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.
Ichida K; Amaya Y; Okamoto K; Nishino T
Int J Mol Sci; 2012 Nov; 13(11):15475-95. PubMed ID: 23203137
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxine-dependent epilepsy with elevated urinary α-amino adipic semialdehyde in molybdenum cofactor deficiency.
Struys EA; Nota B; Bakkali A; Al Shahwan S; Salomons GS; Tabarki B
Pediatrics; 2012 Dec; 130(6):e1716-9. PubMed ID: 23147983
[TBL] [Abstract][Full Text] [Related]
12. Molybdenum cofactor deficiency.
Atwal PS; Scaglia F
Mol Genet Metab; 2016 Jan; 117(1):1-4. PubMed ID: 26653176
[TBL] [Abstract][Full Text] [Related]
13. Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.
Jakubiczka-Smorag J; Santamaria-Araujo JA; Metz I; Kumar A; Hakroush S; Brueck W; Schwarz G; Burfeind P; Reiss J; Smorag L
Hum Genet; 2016 Jul; 135(7):813-26. PubMed ID: 27138983
[TBL] [Abstract][Full Text] [Related]
14. Using Next-Generation Sequencing to Identify a Mutation in Human MCSU that is Responsible for Type II Xanthinuria.
Zhou Y; Zhang X; Ding R; Li Z; Hong Q; Wang Y; Zheng W; Geng X; Fan M; Cai G; Chen X; Wu D
Cell Physiol Biochem; 2015; 35(6):2412-21. PubMed ID: 25967871
[TBL] [Abstract][Full Text] [Related]
15. Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiency.
Mechler K; Mountford WK; Hoffmann GF; Ries M
Genet Med; 2015 Dec; 17(12):965-70. PubMed ID: 25764214
[TBL] [Abstract][Full Text] [Related]
16. Xanthinuria type I: a rare cause of urolithiasis.
Arikyants N; Sarkissian A; Hesse A; Eggermann T; Leumann E; Steinmann B
Pediatr Nephrol; 2007 Feb; 22(2):310-4. PubMed ID: 17115198
[TBL] [Abstract][Full Text] [Related]
17. Molybdenum cofactor deficiency: review of 12 cases (MoCD and review).
Bayram E; Topcu Y; Karakaya P; Yis U; Cakmakci H; Ichida K; Kurul SH
Eur J Paediatr Neurol; 2013 Jan; 17(1):1-6. PubMed ID: 23122324
[TBL] [Abstract][Full Text] [Related]
18. Hereditary xanthinuria in a goat.
Vail KJ; Tate NM; Likavec T; Minor KM; Gibbons PM; Rech RR; Furrow E
J Vet Intern Med; 2019 Mar; 33(2):1009-1014. PubMed ID: 30758870
[TBL] [Abstract][Full Text] [Related]
19. Molybdenum cofactor deficiency-phenotypic variability in a family with a late-onset variant.
Hughes EF; Fairbanks L; Simmonds HA; Robinson RO
Dev Med Child Neurol; 1998 Jan; 40(1):57-61. PubMed ID: 9459218
[TBL] [Abstract][Full Text] [Related]
20. Effect of allopurinol on the xanthinuria in a patient with molybdenum cofactor deficiency.
van Gennip AH; Mandel H; Stroomer LE; van Cruchten AG
Adv Exp Med Biol; 1994; 370():375-8. PubMed ID: 7660932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
